Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor

Background: Protein S (PS) has direct anticoagulant activity, independently of activated protein C (APC). The mechanisms underlying this activity remain unclear, because PS preparations differ in activity, giving rise to conflicting results. Some purification procedures result in loss of intramolecu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thrombosis and haemostasis 2010-09, Vol.8 (9), p.1976-1985
Hauptverfasser: FERNANDES, N., MOSNIER, L. O., TONNU, L., HEEB, M. J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1985
container_issue 9
container_start_page 1976
container_title Journal of thrombosis and haemostasis
container_volume 8
creator FERNANDES, N.
MOSNIER, L. O.
TONNU, L.
HEEB, M. J.
description Background: Protein S (PS) has direct anticoagulant activity, independently of activated protein C (APC). The mechanisms underlying this activity remain unclear, because PS preparations differ in activity, giving rise to conflicting results. Some purification procedures result in loss of intramolecular Zn2+, which is essential for inhibition of prothrombinase. Objective: To investigate the inhibition of extrinsic factor (F)Xase by Zn2+‐containing PS. Methods: Purified component extrinsic FXase assays were used to determine FXa generation in the presence and absence of PS and/or tissue factor pathway inhibitor (TFPI). Binding assays, immunoblots and thrombin generation assays in plasma supported the FXase data. Results: Zn2+‐containing PS potently inhibited extrinsic FXase in the presence of saturating phospholipids, independently of TFPI, whereas inhibition of extrinsic FXase by Zn2+‐deficient PS required TFPI. Immunoblots for FXa and functional assays showed that Zn2+‐containing PS inhibited primarily the quantity of FXa formed by tissue factor (TF)–FVIIa, rather than FXa amidolytic activity. Zn2+‐containing PS, but not Zn2+‐deficient PS, bound to TF with high affinity (Kd app = 41 nm) and targeted TF function. Binding of PS to FVIIa was negligible, whereas PS showed appreciable binding to FX. Increasing FX concentrations 10‐fold reduced PS inhibition five‐fold, suggesting that PS inhibition of FXase is FX‐dependent. PS also exhibited TFPI‐independent and APC‐independent anticoagulant activity during TF‐initiated thrombin generation in plasma. Conclusions: PS that retains native Zn2+ also retains anticoagulant functions independently of APC and TFPI. Inhibition of extrinsic FXase by PS at saturating levels of phospholipids depends on PS retention of intramolecular Zn2+, interaction with FX, and, particularly, interaction with TF.
doi_str_mv 10.1111/j.1538-7836.2010.03919.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2955986</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>762285731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4039-61678da749fa52f107ecd38d65d9b1f88277236da1a0ed80200fd7f33b848c3</originalsourceid><addsrcrecordid>eNqNkUtuFDEURa0IRD6whahmDFB3_Kkq2wOQUARJUCQGySBiYrn9SbtVbRe2O-kewRKyhKwlS8lKcNEfwSwe2E9-91w_6wJQIThGZZ3MxqghbEQZaccYlltIOOLj5R442DVebWtOyD44TGkGIeINhm_APoY1xzVFB-DXD48_PP9-UMFn6bzzt1UfQzbOPz1eVc5P3cTlVJlljs4npyorVQ7x6fGmQKV0dzIPkArzvjPLQmjTm7L53K2qYKvsUlqYDVb1Mk_v5WprHOJb8NrKLpl3m_MIXH39cn16Prr8fnZx-vlypOryt1GLWsq0pDW3ssEWQWqUJky3jeYTZBnDlGLSaokkNJpBDKHV1BIyYTVT5Ah8Wrv2i8ncaFWmi7ITfXRzGVciSCf-73g3FbfhTmDeNJy1xeD9xiCGnwuTspi7pEzXSW_CIgnaYswaSlBRsrVSxZBSNHb3CoJiCE_MxJCLGDISQ3jib3hiWdDjf6fcgdu0iuDjWnDvOrN6sbH4dn0-VOQPR_KwcA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>762285731</pqid></control><display><type>article</type><title>Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>FERNANDES, N. ; MOSNIER, L. O. ; TONNU, L. ; HEEB, M. J.</creator><creatorcontrib>FERNANDES, N. ; MOSNIER, L. O. ; TONNU, L. ; HEEB, M. J.</creatorcontrib><description>Background: Protein S (PS) has direct anticoagulant activity, independently of activated protein C (APC). The mechanisms underlying this activity remain unclear, because PS preparations differ in activity, giving rise to conflicting results. Some purification procedures result in loss of intramolecular Zn2+, which is essential for inhibition of prothrombinase. Objective: To investigate the inhibition of extrinsic factor (F)Xase by Zn2+‐containing PS. Methods: Purified component extrinsic FXase assays were used to determine FXa generation in the presence and absence of PS and/or tissue factor pathway inhibitor (TFPI). Binding assays, immunoblots and thrombin generation assays in plasma supported the FXase data. Results: Zn2+‐containing PS potently inhibited extrinsic FXase in the presence of saturating phospholipids, independently of TFPI, whereas inhibition of extrinsic FXase by Zn2+‐deficient PS required TFPI. Immunoblots for FXa and functional assays showed that Zn2+‐containing PS inhibited primarily the quantity of FXa formed by tissue factor (TF)–FVIIa, rather than FXa amidolytic activity. Zn2+‐containing PS, but not Zn2+‐deficient PS, bound to TF with high affinity (Kd app = 41 nm) and targeted TF function. Binding of PS to FVIIa was negligible, whereas PS showed appreciable binding to FX. Increasing FX concentrations 10‐fold reduced PS inhibition five‐fold, suggesting that PS inhibition of FXase is FX‐dependent. PS also exhibited TFPI‐independent and APC‐independent anticoagulant activity during TF‐initiated thrombin generation in plasma. Conclusions: PS that retains native Zn2+ also retains anticoagulant functions independently of APC and TFPI. Inhibition of extrinsic FXase by PS at saturating levels of phospholipids depends on PS retention of intramolecular Zn2+, interaction with FX, and, particularly, interaction with TF.</description><identifier>ISSN: 1538-7933</identifier><identifier>ISSN: 1538-7836</identifier><identifier>EISSN: 1538-7836</identifier><identifier>DOI: 10.1111/j.1538-7836.2010.03919.x</identifier><identifier>PMID: 20492471</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Anticoagulants - chemistry ; Anticoagulants - therapeutic use ; blood coagulation ; extrinsic pathway ; Factor X - chemistry ; Factor Xa - chemistry ; Humans ; Kinetics ; Lipoproteins - chemistry ; Phospholipids - chemistry ; Protein Binding ; Protein C - chemistry ; Protein S - metabolism ; Recombinant Proteins - chemistry ; Thromboplastin - chemistry ; Time Factors ; Zinc - chemistry ; Zinc - pharmacology ; zinc metalloprotein</subject><ispartof>Journal of thrombosis and haemostasis, 2010-09, Vol.8 (9), p.1976-1985</ispartof><rights>2010 International Society on Thrombosis and Haemostasis</rights><rights>2010 International Society on Thrombosis and Haemostasis.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4039-61678da749fa52f107ecd38d65d9b1f88277236da1a0ed80200fd7f33b848c3</citedby><cites>FETCH-LOGICAL-c4039-61678da749fa52f107ecd38d65d9b1f88277236da1a0ed80200fd7f33b848c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20492471$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FERNANDES, N.</creatorcontrib><creatorcontrib>MOSNIER, L. O.</creatorcontrib><creatorcontrib>TONNU, L.</creatorcontrib><creatorcontrib>HEEB, M. J.</creatorcontrib><title>Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor</title><title>Journal of thrombosis and haemostasis</title><addtitle>J Thromb Haemost</addtitle><description>Background: Protein S (PS) has direct anticoagulant activity, independently of activated protein C (APC). The mechanisms underlying this activity remain unclear, because PS preparations differ in activity, giving rise to conflicting results. Some purification procedures result in loss of intramolecular Zn2+, which is essential for inhibition of prothrombinase. Objective: To investigate the inhibition of extrinsic factor (F)Xase by Zn2+‐containing PS. Methods: Purified component extrinsic FXase assays were used to determine FXa generation in the presence and absence of PS and/or tissue factor pathway inhibitor (TFPI). Binding assays, immunoblots and thrombin generation assays in plasma supported the FXase data. Results: Zn2+‐containing PS potently inhibited extrinsic FXase in the presence of saturating phospholipids, independently of TFPI, whereas inhibition of extrinsic FXase by Zn2+‐deficient PS required TFPI. Immunoblots for FXa and functional assays showed that Zn2+‐containing PS inhibited primarily the quantity of FXa formed by tissue factor (TF)–FVIIa, rather than FXa amidolytic activity. Zn2+‐containing PS, but not Zn2+‐deficient PS, bound to TF with high affinity (Kd app = 41 nm) and targeted TF function. Binding of PS to FVIIa was negligible, whereas PS showed appreciable binding to FX. Increasing FX concentrations 10‐fold reduced PS inhibition five‐fold, suggesting that PS inhibition of FXase is FX‐dependent. PS also exhibited TFPI‐independent and APC‐independent anticoagulant activity during TF‐initiated thrombin generation in plasma. Conclusions: PS that retains native Zn2+ also retains anticoagulant functions independently of APC and TFPI. Inhibition of extrinsic FXase by PS at saturating levels of phospholipids depends on PS retention of intramolecular Zn2+, interaction with FX, and, particularly, interaction with TF.</description><subject>Anticoagulants - chemistry</subject><subject>Anticoagulants - therapeutic use</subject><subject>blood coagulation</subject><subject>extrinsic pathway</subject><subject>Factor X - chemistry</subject><subject>Factor Xa - chemistry</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Lipoproteins - chemistry</subject><subject>Phospholipids - chemistry</subject><subject>Protein Binding</subject><subject>Protein C - chemistry</subject><subject>Protein S - metabolism</subject><subject>Recombinant Proteins - chemistry</subject><subject>Thromboplastin - chemistry</subject><subject>Time Factors</subject><subject>Zinc - chemistry</subject><subject>Zinc - pharmacology</subject><subject>zinc metalloprotein</subject><issn>1538-7933</issn><issn>1538-7836</issn><issn>1538-7836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtuFDEURa0IRD6whahmDFB3_Kkq2wOQUARJUCQGySBiYrn9SbtVbRe2O-kewRKyhKwlS8lKcNEfwSwe2E9-91w_6wJQIThGZZ3MxqghbEQZaccYlltIOOLj5R442DVebWtOyD44TGkGIeINhm_APoY1xzVFB-DXD48_PP9-UMFn6bzzt1UfQzbOPz1eVc5P3cTlVJlljs4npyorVQ7x6fGmQKV0dzIPkArzvjPLQmjTm7L53K2qYKvsUlqYDVb1Mk_v5WprHOJb8NrKLpl3m_MIXH39cn16Prr8fnZx-vlypOryt1GLWsq0pDW3ssEWQWqUJky3jeYTZBnDlGLSaokkNJpBDKHV1BIyYTVT5Ah8Wrv2i8ncaFWmi7ITfXRzGVciSCf-73g3FbfhTmDeNJy1xeD9xiCGnwuTspi7pEzXSW_CIgnaYswaSlBRsrVSxZBSNHb3CoJiCE_MxJCLGDISQ3jib3hiWdDjf6fcgdu0iuDjWnDvOrN6sbH4dn0-VOQPR_KwcA</recordid><startdate>201009</startdate><enddate>201009</enddate><creator>FERNANDES, N.</creator><creator>MOSNIER, L. O.</creator><creator>TONNU, L.</creator><creator>HEEB, M. J.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201009</creationdate><title>Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor</title><author>FERNANDES, N. ; MOSNIER, L. O. ; TONNU, L. ; HEEB, M. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4039-61678da749fa52f107ecd38d65d9b1f88277236da1a0ed80200fd7f33b848c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anticoagulants - chemistry</topic><topic>Anticoagulants - therapeutic use</topic><topic>blood coagulation</topic><topic>extrinsic pathway</topic><topic>Factor X - chemistry</topic><topic>Factor Xa - chemistry</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Lipoproteins - chemistry</topic><topic>Phospholipids - chemistry</topic><topic>Protein Binding</topic><topic>Protein C - chemistry</topic><topic>Protein S - metabolism</topic><topic>Recombinant Proteins - chemistry</topic><topic>Thromboplastin - chemistry</topic><topic>Time Factors</topic><topic>Zinc - chemistry</topic><topic>Zinc - pharmacology</topic><topic>zinc metalloprotein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FERNANDES, N.</creatorcontrib><creatorcontrib>MOSNIER, L. O.</creatorcontrib><creatorcontrib>TONNU, L.</creatorcontrib><creatorcontrib>HEEB, M. J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FERNANDES, N.</au><au>MOSNIER, L. O.</au><au>TONNU, L.</au><au>HEEB, M. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor</atitle><jtitle>Journal of thrombosis and haemostasis</jtitle><addtitle>J Thromb Haemost</addtitle><date>2010-09</date><risdate>2010</risdate><volume>8</volume><issue>9</issue><spage>1976</spage><epage>1985</epage><pages>1976-1985</pages><issn>1538-7933</issn><issn>1538-7836</issn><eissn>1538-7836</eissn><abstract>Background: Protein S (PS) has direct anticoagulant activity, independently of activated protein C (APC). The mechanisms underlying this activity remain unclear, because PS preparations differ in activity, giving rise to conflicting results. Some purification procedures result in loss of intramolecular Zn2+, which is essential for inhibition of prothrombinase. Objective: To investigate the inhibition of extrinsic factor (F)Xase by Zn2+‐containing PS. Methods: Purified component extrinsic FXase assays were used to determine FXa generation in the presence and absence of PS and/or tissue factor pathway inhibitor (TFPI). Binding assays, immunoblots and thrombin generation assays in plasma supported the FXase data. Results: Zn2+‐containing PS potently inhibited extrinsic FXase in the presence of saturating phospholipids, independently of TFPI, whereas inhibition of extrinsic FXase by Zn2+‐deficient PS required TFPI. Immunoblots for FXa and functional assays showed that Zn2+‐containing PS inhibited primarily the quantity of FXa formed by tissue factor (TF)–FVIIa, rather than FXa amidolytic activity. Zn2+‐containing PS, but not Zn2+‐deficient PS, bound to TF with high affinity (Kd app = 41 nm) and targeted TF function. Binding of PS to FVIIa was negligible, whereas PS showed appreciable binding to FX. Increasing FX concentrations 10‐fold reduced PS inhibition five‐fold, suggesting that PS inhibition of FXase is FX‐dependent. PS also exhibited TFPI‐independent and APC‐independent anticoagulant activity during TF‐initiated thrombin generation in plasma. Conclusions: PS that retains native Zn2+ also retains anticoagulant functions independently of APC and TFPI. Inhibition of extrinsic FXase by PS at saturating levels of phospholipids depends on PS retention of intramolecular Zn2+, interaction with FX, and, particularly, interaction with TF.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>20492471</pmid><doi>10.1111/j.1538-7836.2010.03919.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1538-7933
ispartof Journal of thrombosis and haemostasis, 2010-09, Vol.8 (9), p.1976-1985
issn 1538-7933
1538-7836
1538-7836
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2955986
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Anticoagulants - chemistry
Anticoagulants - therapeutic use
blood coagulation
extrinsic pathway
Factor X - chemistry
Factor Xa - chemistry
Humans
Kinetics
Lipoproteins - chemistry
Phospholipids - chemistry
Protein Binding
Protein C - chemistry
Protein S - metabolism
Recombinant Proteins - chemistry
Thromboplastin - chemistry
Time Factors
Zinc - chemistry
Zinc - pharmacology
zinc metalloprotein
title Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A09%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Zn2+%E2%80%90containing%20protein%C2%A0S%20inhibits%20extrinsic%20factor%C2%A0X%E2%80%90activating%20complex%20independently%20of%20tissue%20factor%20pathway%20inhibitor&rft.jtitle=Journal%20of%20thrombosis%20and%20haemostasis&rft.au=FERNANDES,%20N.&rft.date=2010-09&rft.volume=8&rft.issue=9&rft.spage=1976&rft.epage=1985&rft.pages=1976-1985&rft.issn=1538-7933&rft.eissn=1538-7836&rft_id=info:doi/10.1111/j.1538-7836.2010.03919.x&rft_dat=%3Cproquest_pubme%3E762285731%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=762285731&rft_id=info:pmid/20492471&rfr_iscdi=true